These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 33295601)
1. From strongyloidiasis to disseminated mucormycosis: the story of an HTLV-1-infected migrant. Autier B; Chesnay A; Mayence C; Houcke S; Guégan H; Demar M; Blanchet D J Travel Med; 2021 Aug; 28(6):. PubMed ID: 33295601 [No Abstract] [Full Text] [Related]
2. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report. Ashida C; Kinoshita K; Nozaki Y; Funauchi M BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937 [TBL] [Abstract][Full Text] [Related]
3. Duodenal obstruction due to Harshan M; Niyas VKM; Arjun R Trop Doct; 2022 Oct; 52(4):596-597. PubMed ID: 35833224 [No Abstract] [Full Text] [Related]
4. Disseminated Strongyloides stercoralis infection with a cutaneous presentation in an immunosuppressed patient. Benvenuti F; Carrascosa JM; Boada A; Ferrandiz C Eur J Dermatol; 2009; 19(4):404-5. PubMed ID: 19467975 [No Abstract] [Full Text] [Related]
5. Strongyloides stercoralis infection in a migrant on dialysis. Gobbi F; Fischer MS; Ragusa A; Buonfrate D J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30521011 [No Abstract] [Full Text] [Related]
6. Case Report: De Souza JN; Soares BNRR; Goes LL; Lima CS; Barreto NMPV; Jacobina BS; Gonçalves N; Teixeira MCA; Galvão-Castro B; Grassi MFR; Soares NM Am J Trop Med Hyg; 2018 Dec; 99(6):1583-1586. PubMed ID: 30277207 [No Abstract] [Full Text] [Related]
7. Strongyloides stercoralis central nervous system dissemination in a migrant misdiagnosed with eosinophilic granulomatosis with polyangiitis. Comelli A; Mangioni D; Scaramella L; Maraschini A; Gaudino C; Folli C; Ceriotti F; Triulzi F; Canetta C; Gori A; Bandera A J Travel Med; 2022 Jan; 29(1):. PubMed ID: 34718667 [No Abstract] [Full Text] [Related]
8. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Carvalho EM; Da Fonseca Porto A Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684 [TBL] [Abstract][Full Text] [Related]
9. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection. Hirata T; Uchima N; Kishimoto K; Zaha O; Kinjo N; Hokama A; Sakugawa H; Kinjo F; Fujita J Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078 [TBL] [Abstract][Full Text] [Related]
10. Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1. Satoh M; Kiyuna S; Shiroma Y; Toma H; Kokaze A; Sato Y Clin Exp Immunol; 2003 Sep; 133(3):391-6. PubMed ID: 12930366 [TBL] [Abstract][Full Text] [Related]
11. Case Report: Disseminated Paracoccidioidomycosis and Strongyloides Hyperinfection in a Patient with Human T-Lymphotropic Virus Type 1/2 Infection. Montenegro-Idrogo J; Chiappe-Gonzalez A; Vicente-Lozano E; Cornejo-Venegas G; Resurrección-Delgado C Am J Trop Med Hyg; 2024 May; 110(5):961-964. PubMed ID: 38531110 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of Strongyloides stercoralis infection in patients with HTLV-1. Pereira Vieira Barreto NM; Brito Farias MM; Oliveira CL; Almeida Costa Araujo W; Rios Grassi MF; Nascimento de Souza J; Soares Jacobina B; Aquino Teixeira MC; Galvão-Castro B; Matos Soares N Biomedica; 2022 Mar; 42(1):31-40. PubMed ID: 35471168 [TBL] [Abstract][Full Text] [Related]
14. Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels. Salles F; Bacellar A; Amorim M; Orge G; Sundberg M; Lima M; Santos S; Porto A; Carvalho E Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):526-9. PubMed ID: 23843560 [TBL] [Abstract][Full Text] [Related]
16. Strongyloides stercoralis: a cause of morbidity and mortality for indigenous people in Central Australia. Einsiedel L; Fernandes L Intern Med J; 2008 Sep; 38(9):697-703. PubMed ID: 19143887 [TBL] [Abstract][Full Text] [Related]
17. Atypical clinical presentation of strongyloidiasis in a patient co-infected with human T cell lymphotrophic virus type I. Porto MA; Alcântara LM; Leal M; Castro N; Carvalho EM Am J Trop Med Hyg; 2005 Feb; 72(2):124-5. PubMed ID: 15741545 [TBL] [Abstract][Full Text] [Related]
18. Gastric strongyloidiasis and infection by the human T cell lymphotropic virus type 1 (HTLV-1). Lambertucci JR; Leão FC; Barbosa AJ Rev Soc Bras Med Trop; 2003; 36(4):541-2. PubMed ID: 12937738 [No Abstract] [Full Text] [Related]
19. Triple infection with HIV-1, HTLV-1 and Strongyloides stercoralis, rendering CD4+ T-cell counts a misleading entity. Janssen S; Rossatanga EG; Jurriaans S; ten Berge IJ; Grobusch MP Antivir Ther; 2013; 18(7):949-51. PubMed ID: 24152969 [TBL] [Abstract][Full Text] [Related]
20. [Recurrent strongyloidiasis as an indicator of HTLV-1 infection]. Richter J; Schwarz U; Duwe S; Ellerbrok H; Poggensee G; Pauli G Dtsch Med Wochenschr; 2005 Apr; 130(16):1007-10. PubMed ID: 15830313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]